Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: COLLAPSE; CARDIAC ARREST; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IE-HPRA-2021-068553. An 84-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 04Mar2021 (at the age of 84-years-old) (Batch/Lot Number: ER2659) as 0.3 ml single for covid-19 immunisation. Medical history included cardiac failure, chronic obstructive pulmonary disease, hypertension, atrial fibrillation. Concomitant medications included dutasteride, tamsulosin hydrochloride (COMBODART); pravastatin; mirabegron (BETMIGA); salbutamol; bisoprolol; rivaroxaban; tiotropium bromide (SPIRIVA RESPIMAT); lactulose; esomeprazole; spironolactone; bumetanide (BURINEX); fluticasone propionate, salmeterol (SERETIDE EVOHALER); all taken for unspecified indications, start and stop dates were not reported. On 09Mar2021, the patient collapsed at home/also reported as syncope. The patient was brought by ambulance to the Emergency Department (ED). The patient experienced cardiac arrest and standard resuscitation was performed. The reporter outlined that it was unclear if the event was in any way related to vaccine administration, but the reporter was reporting as per protocol. In Mar2021, the patient died. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. Batch/lot number already provided.; Reported Cause(s) of Death: Syncope; Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166